实用医学杂志 ›› 2023, Vol. 39 ›› Issue (8): 923-927.doi: 10.3969/j.issn.1006⁃5725.2023.08.001

• 临床新进展 •    下一篇

色素上皮衍生因子在角膜疾病治疗中的应用 

雷亦笑 章梦一 陈京霞 邹秀兰 邹玉平 彭亮红   

  1. 解放军南部战区总医院眼科(广州 510010)

  • 出版日期:2023-04-25 发布日期:2023-04-25
  • 通讯作者: 彭亮红 E⁃mail:pzhocean@163.com
  • 基金资助:

    广东省自然科学基金-面上项目(编号:2019A1515 011732);南部战区总医院院内课题(编号:2021NZA002) 


Application of pigment epithelium derived factor in the treatment of corneal diseases

LEI Yixiao,ZHANG Mengyi,CHEN Jingxia,ZOU Xiulan,ZOU Yuping,PENG Lianghong.   

  1. Department of Ophthalmology,General Hospital of Southern Theatre Command,PLA,Guangzhou 510010,China

  • Online:2023-04-25 Published:2023-04-25
  • Contact: PENG Lianghong E⁃mail:pzhocean@163.com

摘要:

色素上皮衍生因子(PEDF)是一种 50 kDa 分泌型糖蛋白,具有多种生物学效应和生理活性, 包括抗血管生成、抗肿瘤和神经营养活性等。从1987年PEDF被发现以来,许多研究证实PEDF或PEDF的 多肽片段具有治疗多种疾病的潜力,尤其是伴有新生血管形成、神经损伤、肿瘤等病理改变的疾病。角膜 疾病常出现新生血管浸润、炎性反应、神经损伤等,目前 PEDF 在角膜疾病治疗中的应用也逐渐成为研究 热点,现将此方面的研究进展进行综述。

关键词:

色素上皮衍生因子, 角膜疾病, 治疗

Abstract:

Pigment epithelium derived factor(PEDF)is a type of 50 kDa secretory glycoprotein with a variety of biological effects and physiological activities,including anti ⁃angiogenesis,anti ⁃tumor and neurotrophic activities. Since the discovery of PEDF in 1987,many studies have confirmed that PEDF or its polypeptide frag⁃ ments have the potential to treat a variety of diseases,especially those with pathological changes such as neovascu⁃ larization,nerve injury and tumor. Corneal diseases often accompanied with neovascular infiltration,inflammatory reaction,and nerve damage. At present,the application of PEDF in the treatment of corneal diseases has gradually become a research hotspot. This paper reviews the research progress in this area.

Key words:

corneal epithelium?derived factor, corneal diseases, treatment